Regulation of iron acquisition and storage: Consequences for iron-linked disorders

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 1, 2008, Pages 72-81

  De Domenico, Ivana ^a   McVey Ward, Diane ^a   Kaplan, Jerry ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD79 ANTIGEN; CERULOPLASMIN; FERROPORTIN; HEPCIDIN; HEPHAESTIN; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN; TRANSFERRIN RECEPTOR 2;

ANEMIA; GENE CONTROL; HEMOCHROMATOSIS; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; IRON BALANCE; IRON DEFICIENCY; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS;

MAMMALIA;

EID: 37549059612     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2295     Document Type: Review

References (99)

1. May, P. M. & Williams, D. R. in Iron in Biochemistry and Medicine (eds Jacobs, A. & Worwood, M.) 1-28 (Academic Press, New York, 1980).
2. Shayeghi, M. et al. Identification of an intestinal heme transporter. Cell 122, 789-801 (2005).
3. Qiu, A. et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127, 917-928 (2006).
4. Gunshin, H. et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 106, 2879-2883 (2005).
5. Gunshin, H. et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488 (1997). Identified the apical iron transporter DMT1 by expression cloning.
6. Fleming, M. D. et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet. 16, 383-386 (1997). Identified the apical iron transporter DMT1 by positional cloning.
7. Fleming, M. D. et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl Acad. Sci. USA 95, 1148-1153 (1998).
8. Gunshin, H. et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 115, 1258-1266 (2005).
9. Abboud, S. & Haile, D. J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-19912 (2000).
10. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
11. McKie, A. T. et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309 (2000). References 9-11 reported the discovery of the only known iron exporter.
12. Donovan, A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200 (2005).
13. Liu, X. B., Yang, F. & Haile, D. J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 35, 33-46 (2005).
14. De Domenico, I., Ward, D. M., Musci, G. & Kaplan, J. Evidence for the multimeric structure of ferroportin. Blood 109, 2205-2209 (2007).
15. Osaki, S., Johnson, D. A. & Frieden, E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751 (1966). A seminal study that connected iron and copper metabolism.
16. Roeser, H. P., Lee, G. R., Nacht, S. & Cartwright, G. E. The role of ceruloplasmin in iron metabolism. J. Clin. Invest. 49, 2408-2417 (1970).
17. Bush, J. A. et al. Studies on copper metabolism. XIX. The kinetics of iron metabolism and erythrocyte life-span in copper-deficient swine. J. Exp. Med. 103, 701-712 (1956).
18. Ragan, H. A., Nacht, S., Lee, G. R., Bishop, C. R. & Cartwright, G. E. Effect of ceruloplasmin on plasma iron in copper-deficient swine. Am. J. Physiol. 217, 1320-1323 (1969).
19. Harris, Z. L., Durley, A. P., Man, T. K. & Gitlin, J. D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl Acad. Sci. USA 96, 10812-10817 (1999).
20. Jeong, S. Y. & David, S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27144-27148 (2003).
21. Harris, Z. L., Klomp, L. W. & Gitlin, J. D. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am. J. Clin. Nutr. 67, 972S-977S (1998).
22. De Domenico, I. et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26, 2823-2831 (2007).
23. Vulpe, C. D. et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nature Genet. 21, 195-199 (1999).
24. Hamill, R. L., Woods, J. C. & Cook, B. A. Congenital atransferrinemia. A case report and review of the literature. Am. J. Clin. Pathol. 96, 215-218 (1991).
25. Bernstein, S. E. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 110, 690-705 (1987).
26. Aisen, P. Transferrin receptor 1. Int. J. Biochem. Cell Biol. 36, 2137-2143 (2004).
27. Cheng, Y., Zak, O., Aisen, P., Harrison, S. C. & Walz, T. Structure of the human transferrin receptor-transferrin complex. Cell 116, 565-576 (2004).
28. Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F. & Andrews, N. C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nature Genet. 21, 396-399 (1999).
29. Sipe, D. M. & Murphy, R. F. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J. Biol. Chem. 266, 8002-8007 (1991).
30. Bali, P. K., Zak, O. & Aisen, P. A new role for the transferrin receptor in the release of iron from transferrin. Biochemistry 30, 324-328 (1991).
31. Ohgami, R. S. et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nature Genet. 37, 1264-1269 (2005).
32. van Renswoude, J., Bridges, K. R., Harford, J. B. & Klausner, R. D. Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc. Natl Acad. Sci. USA 79, 6186-6190 (1982).
33. Dautry-Varsat, A., Ciechanover, A. & Lodish, H. F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 80, 2258-2262 (1983).
34. Oudit, G. Y. et al. L-type Ca2 + channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature Med. 9, 1187-1194 (2003).
35. Oudit, G. Y., Trivieri, M. G., Khaper, N., Liu, P. P. & Backx, P. H. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J. Mol. Med. 84, 349-364 (2006).
36. Liuzzi, J. P., Aydemir, F., Nam, H., Knutson, M. D. & Cousins, R. J. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc. Natl Acad. Sci. USA 103, 13612-13617 (2006).
37. Theil, E. C. Iron, ferritin, and nutrition. Annu. Rev. Nutr. 24, 327-343 (2004).
38. De Domenico, I. et al. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 25, 5396-5404 (2006).
39. Kwak, E. L., Larochelle, D. A., Beaumont, C., Torti, S. V. & Torti, F. M. Role for NF-κB in the regulation of ferritin H by tumor necrosis factor-α. J. Biol. Chem. 270, 15285-15293 (1995).
40. Ponka, P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 1-25 (1997).
41. Rouault, T. A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nature Chem. Biol. 2, 406-414 (2006).
42. Galy, B., Ferring, D., Benesova, M., Benes, V. & Hentze, M. W. Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo. RNA 10, 1019-1025 (2004).
43. Delaby, C., Pilard, N., Goncalves, A. S., Beaumont, C. & Canonne-Hergaux, F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 106, 3979-3984 (2005).
44. Mok, H. et al. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131, 1859-1868 (2004).
45. Crosby, W. H. Mucosal block. An evaluation of concepts relating to control of iron absorption. Semin. Hematol. 3, 299-313 (1966).
46. Frazer, D. M. et al. A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut 52, 340-346 (2003).
47. Pak, M., Lopez, M. A., Gabayan, V., Ganz, T. & Rivera, S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108, 3730-3735 (2006).
48. Loreal, O. et al. Hepcidin in iron metabolism. Curr. Protein Pept. Sci. 6, 279-291 (2005).
49. Ganz, T. Hepcidin - a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract. Res. Clin. Haematol. 18, 171-182 (2005).
50. Ganz, T. Defensins and host defense. Science 286, 420-421 (1999).
51. Nemeth, E. et al. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107, 328-333 (2006).
52. Nicolas, G. et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl Acad. Sci. USA 98, 8780-8785 (2001). The first report of hepcidin as an iron metabolism regulatory protein.
53. Roetto, A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genet. 33, 21-22 (2003).
54. Nicolas, G. et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl Acad. Sci. USA 99, 4596-4601. (2002).
55. Weinstein, D. A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781 (2002).
56. De Domenico, I. et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18, 2569-2578 (2007).
57. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004). Identified the connection between hepcidin and ferroportin in regulating iron export.
58. De Domenico, I. et al. The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl Acad. Sci. USA 102, 8955-8960 (2005). Described how mutations in ferroportin give rise to dominantly inherited haemochromatosis.
59. Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044 (2002).
60. Babitt, J., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C. & Lin, H. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117, 1933-1939 (2007).
61. Babitt, J. L. et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genet. 38, 531-539 (2006).
62. Wang, R. H. et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2, 399-409 (2005). Described a role for the SMAD system in hepcidin expression.
63. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276 (2004).
64. Kaelin, W. G. Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem. Biophys. Res. Commun. 338, 627-638 (2005).
65. Peyssonnaux, C. et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 117, 1926-1932 (2007).
66. Yoon, D. et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J. Biol. Chem. 281, 25703-25711 (2006).
67. Tanno, T. et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Med. 13, 1096-1101 (2007). Describes an erythroid signal that regulates hepcidin expression.
68. Crosby, W. H. Hemochromatosis: the unsolved problems. Semin. Hematol. 14, 135-143 (1977).
69. Craven, C. M. et al. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc. Natl Acad. Sci. USA 84, 3457-3461 (1987).
70. Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399-408 (1996). Identified the mutated gene (HFE) that is responsible for the most common form of hereditary haemochromatosis.
71. Feder, J. N. et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl Acad. Sci. USA 95, 1472-1477 (1998).
72. Feder, J. N. et al. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272, 14025-14028 (1997).
73. Camaschella, C. Juvenile haemochromatosis. Baillieres Clin. Gastroenterol. 12, 227-235 (1998).
74. Papanikolaou, G. et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genet. 36, 77-82 (2004).
75. Lin, L., Goldberg, Y. P. & Ganz, T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106, 2884-2889 (2005).
76. Zhang, A. S. et al. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J. Biol. Chem. 282, 12547-12556 (2007).
77. Camaschella, C. et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genet. 25, 14-15 (2000).
78. Roetto, A. et al. Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol. Dis. 29, 465-470 (2002).
79. Kawabata, H. et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274, 20826-20832 (1999).
80. Johnson, M. B. & Enns, C. A. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104, 4287-4293 (2004).
81. Montosi, G. et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108, 619-623 (2001).
82. Pietrangelo, A. The ferroportin disease. Blood Cells Mol. Dis. 32, 131-138 (2004).
83. Drakesmith, H. et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106, 1092-1097 (2005).
84. Schimanski, L. M. et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096-4102 (2005).
85. McGregor, J. A. et al. Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J. Membr. Biol. 206, 3-7 (2005).
86. Zohn, I.E. et al. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood 109, 4174-4180 (2007).
87. Goncalves, A. S. et al. Wild-type and mutant ferroportins do not form oligomers in transfected cells. Biochem. J. 396, 265-275 (2006).
88. De Domenico, I. et al. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood 28 Aug 2007 (doi:10.1182/blood-2007-07-100248).
89. Cartwright, G. E., Lauritsen, M. A., Jones, P. J., Merrill, I. M. & Wintrobe, M. M. The anemia of infection. I. Hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients. J. Clin. Invest. 25, 65-80 (1946).
90. Schaible, U. E. & Kaufmann, S. H. Iron and microbial infection. Nature Rev. Microbiol. 2, 946-953 (2004).
91. Baraldi-Junkins, C. A., Beck, A. C. & Rothstein, G. Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol. Oncol. Clin. North Am. 14, 45-61 (2000).
92. Bruunsgaard, H., Pedersen, M. & Pedersen, B. K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8, 131-136 (2001).
93. Pietrangelo, A. et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132, 294-300 (2007).
94. Verga Falzacappa, M. V. et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109, 353-358 (2007).
95. Wrighting, D. M. & Andrews, N. C. Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204-3209 (2006).
96. Truksa, J., Peng, H., Lee, P. & Beutler, E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl Acad. Sci. USA 103, 10289-10293 (2006).
97. Bulaj, Z. J. et al. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med. 343, 1529-1535 (2000).
98. Beutler, E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101, 3347-3350 (2003).
99. Wang, F. et al. Genetic variation in Mon 1a affects protein trafficking and modifies macrophage iron loading in mice. Nature Genet. 39, 1025-1032 (2007).